Market Pulse: Equities drifted as tech ambition collided with industrial discipline: Silicon Valley’s hardware-AI ventures wrestled for attention against manufacturing stalwarts refocusing on high-margin software.
Key Movers: Jeff Bezos’s Project Prometheus is staking claims in physical AI, while ABB’s latest margin target shake-up underscores that old-school factories need to evolve or get left behind. CRISPR-driven biotech firms are jockeying for spotlight in next-gen therapies.
Macro & Politics: Washington’s warning to allies on Chinese lending rings hollow when Uncle Sam is the biggest borrower itself—a political whipsaw that can flip market sentiment overnight.
What’s Next: Watch for any word on biotech approvals or fresh Washington commentary on AI oversight to set the tone at open.
📈 Breaking Financial News
Human Gene Editing and the CRISPR Revolution
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier CRISPR (Clustered Regularly Interspaced Short Palindromic Re…),
[Latest] Global NUT Midline Carcinoma Treatment Market Size/Share Worth USD 93.34 Billion by 2034 at a 15.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global NUT Midline Carcinoma Treatment Market size & share revenue was valued at approximately USD 22.67 Billion in 2024 and is expecte…
What is Project Prometheus, the new physical AI startup with Jeff Bezos as co-CEO?
Project Prometheus is reportedly part of a new wave of AI startups and research labs shifting focus from LLMs to building ‘world models’.
ABB Lifts Earnings Margin Target, Eyes Acquisitions to Grow
ABB Ltd. raised its operating profitability target as the Swiss industrial manufacturer benefits from a boom in artificial intelligence applications that’s bolstering demand for its power-grid products.
US warns others to avoid loans from Chinese state banks, but it is biggest recipient
A new report says China funneled billions in hidden loans to U.S. companies over the past quarter century, some targeting industries key to national security
$100 Oil Coming?
CNN/WSJ: Oil prices exploded 6-8% on Iran crisis. Analysts warn $100/barrel if Strait of Hormuz disrupted. While oil stocks swing wildly, there's a steadier way to profit. Marc shows you how.
🔍 Market Analysis & Insights
Poor countries got $1 trillion from China. So did rich ones.
In recent years, China has emerged as a formidable global banking force, disbursing over a trillion dollars in loans across the globe. What once primarily served developing nations is now increasingly directed toward affluent countries.
US has warned others to avoid loans from Chinese state banks. But it’s the biggest recipient of all
WASHINGTON (AP) — For years, Washington has been warning others not to trust loans from Chinese state banks fueling its rise as a superpower. But a new report reveals an ironic twist: The United States is the biggest recipient of all — by far. And the securit…
US has warned others to avoid loans from Chinese state banks. But it's the biggest recipient of all
For years, Washington has been warning others not to trust loans from Chinese state banks fueling its rise as a superpower. China’s state lenders have…
Forging a Future of Opportunity
L'Oréal deputy CEO Barbara Lavernos, E.l.f. Beauty's Ekta Chopra, Kourtney Kardashian-Barker and more speakers from the inaugural Catalysts conference on navigating what's next in beauty.
Johor records over RM90bil in investments as of Q3, highest among all states
JOHOR BARU: Johor is experiencing one of the strongest phases of economic growth in recent history, recording over RM90bil in committed investments as of the third quarter of this year – the highest of any state. Read full story
Wall Street's Secret Crypto Accumulation Exposed The crypto market is heating up
This protocol is fueling billions in transactions while most investors chase headlines… creating what could be the most asymmetric opportunity of 2025! Revealed: Get the name of Wall Street's favorite crypto for just $3 before it potentially skyrockets!
💰 Investment Opportunities
Jeff Bezos Invest Part of the $6.2 Billion Raised for Project Prometheus – His New AI Company
As of November 17, 2025, Jeff Bezos (Amazon founder and Blue Origin owner) has co-founded and is taking an active operational role in a new AI startup called Project Prometheus. Thisis his first formal CEO-like position since stepping down as Amazon CEO in 20…
Amazon founder Jeff Bezos returns to CEO role with AI startup
Jeff Bezos is reportedly returning to hands-on leadership, serving as co-chief executive of a new AI firm called Project Prometheus. The venture, heavily funded, aims to use advanced AI to improve real-world engineering and manufacturing. It gathers top resea…
Why these dozen stocks will remain in focus on Tuesday, November 18, 2025
JSW Energy, Tata Power, Astrazeneca, Sun Pharma, HCL Tech, Paras Defence, RITES, Artificial Electronics, Smartworks, Emcure Pharmaceutical, Latent View, Nuvoco Vistas, Indokem Lab
Stocks in news: RIL, Tata Power, JSW Energy, HCL Tech, Inox Green
Indian markets climbed for a sixth day, with Nifty nearing 26,013. Investors watch global cues amid US market volatility. RIL's beauty arm partnered with Germany's cosnova Beauty. Tata Power commissioned a 300 MW solar project. KPI Green secured a Rs 696.50 c…
“This man is my kind of contrarian” Renowned Futurist, Eric Fry, has been seen o
“Nvidia, Amazon and Tesla are ticking time bombs in investors' portfolios,” he says. Instead, he's sharing three NEW stocks positioned to take over as the tech kingpins of tomorrow. Get Eric's full “Sell This, Buy That” list right here.

Everybody’s focusing on cloud giants and LLM hype, yet they’re overlooking that turning AI into a tangible system—robots that see and act—carries an execution risk few investors appreciate. Project Prometheus (The Indian Express) isn’t just another lab; it’s Bezos betting billions on hardware’s promise to outpace server-bound models. If there’s one lesson from ABB’s margin overhaul (Financial Post), it’s that scaling physical operations is a grind—and hungry markets will punish stumbles.
It’s wild to see Uncle Sam wagging fingers at Beijing loans while piling on the same debt (ABC News, AP)—a political sideshow that could tighten credit spreads and spook biotech backers counting on stable funding for CRISPR trials. Gene editing’s runaway growth (CounterPunch) demands capital certainty, and if Washington’s theatre makes investors skittish, those multi-billion-dollar NUT carcinoma projects (GlobeNewswire) could find their runway shortened.
Don’t just cheerflog these narratives; pick your battleground. Track the dozen names flagged by BusinessLine—it’s a cheat sheet to where volume and volatility will hit first. Then dial into AI-hardware ventures and late-stage gene editors before the herd spots the catalysts. Action favors those who read between the headlines.